Toxic metals such as mercury, aluminum and lead, initiate oxidative stress by forming reactive oxygen products (ROS). Many studies in adults have shown that mercury can contribute to the formation of free radicals and cause cellular damage by initiating oxidative stress in many tissues.6 It has been suggested that mercury impairs cellular antioxidant defense mechanisms, especially by inhibition of key antioxidant enzymes or consumption of the intracellular antioxidant glutathione. Mercury causes this by increasing the production of ROS. Among the heavy metals, mercury is an important metal in terms of its pro-oxidant effect.7,8
Nitric oxide is a biological mediator involved in various physiological and pathophysiological processes that can be found in almost every part of the organism.9 While other free radicals are harmful at any concentration, NO is involved in important physiological events at low concentrations. NO is a bidirectional molecule. It is prooxidant since it creates peroxynitrite-mediated lipid oxidation reactions in cells, and also an antioxidant with its capacity to prevent formation of lipid radical chains.10 However, uncontrolled and excessive NO synthesis is harmful for cells. Thanks to these properties, NO becomes an ideal physiological messenger molecule.11 NO reacts with the superoxide radical and turns into peroxynitrite and plays an important role in cellular damage in high concentration.12 Peroxynitrite forms 3-Nitrotyrosine by adding a nitro group to the phenolic ring of proteins or free form of tyrosine. This reaction can occur spontaneously, or it can be catalyzed by transition metals, SOD, CO2 and myeloperoxidase.13–15 Since nitrotyrosine is the stable end product of peroxynitrite oxidation, measurement of nitrotyrosine has been reported to be a useful marker for detecting NO-dependent in vivo damage.16 While in normal individuals 3-NT levels undetectable in plasma and tissues, it increases significantly in conditions associated with increased NO production and oxidative stress, such as inflammatory and degenerative processes. Although nitrotyrosine and nitric oxide are found in many cells, they have been an effective marker in showing brain damage in recent years. In one study, pregnant mice were exposed to mercury during fetal brain development and checked for nitrergic activity. It was observed that nitrogenous activity increased in the moleculer layer of Dentate Gyrus, Stratum Lacunosum Moleculare, and the Stratum Radiatum.17 High levels of 3-nitrotyrosine have been reported in Atherosclerosis, Multiple Sclerosis, Alzheimer's disease, Parkinson's disease and animal models, cystic fibrosis, asthma, lung diseases, myocardial failure, stroke, amyotrophic lateral sclerosis, chronic hepatitis C, cirrhosis, and diabetes.18,19
In a study conducted by Sumathi et al.20, they gave methyl mercury orally to male visar rats for 21 days. The rats in the control group were given orally Bacopa Maniere extracts (a plant used as a neuroprotective in alternative medicine in India) in addition to methyl mercury. After the applications, they determined that the erythrocyte SOD, CAT and GPx activities were significantly reduced in the group given only methyl mercury. They found that NO2 - and NO3 - levels increased after methyl mercury administration (they thought that these metabolites are a marker of free radical damage and NO production could be effective in oxidative damage), while in the group given Bacopa Maniere extracts together with methyl mercury, oxidative damage associated with methyl mercury in the brain decreased.
In a study by Moneim21, it was investigated whether berberine plant is protective in neurotoxicity and oxidative damage caused by mercury. Adult male albino rats were injected with HgCl2 for 7 days. In this study, oxidative stress occurred by increasing NO production and decreasing antioxidant enzymes after mercury exposure. Conversely in those given beriberine plant before exposure, glutathione increased and NO and lipid peroxidation decreased.
In a study by Karapehlivan22 et al. investigated the protective effect of omega-3 fatty acids on HgCl2 toxicity in mice. In this study, Malondialdehyde (MDA) levels, glutathione, nitric oxide (NO) and total sialic acid (TSA) levels were examined and histopathological changes in selected organs were examined. 28 mice were divided equally into 4 groups. 1. Group; Intraperitoneal saline injected. Group 2; 0.4 mg / kg / day intraperitoneal mercury chloride injected. Group 3; 0.4 mg / kg / day mercury chloride intraperitoneally and simultaneously subcutaneously 0.5 g / kg / day, omega-3 fatty acid applied. Group 4; only 0.5 g/kg/day omega-3 fatty acid applied. In this study, all applications continued for 7 days. Compared to Group 1, MDA, NO and TSA levels were found to be higher in group 2 and lower in group 3 and 4. The highest GSH level was found in Group 4. Histopathologically, severe degeneration of liver and kidney was observed in Group II animals. In conclusion, with this study Karapehlivan et al. showed that omega 3 fatty acid can reduce mercury chloride-induced toxicity by improving the antioxidant system and acute phase response in mice.
Durak23 et al. evaluated MDA and SOD, CAT and GPx activities by incubating erythrocytes which obtained from healthy male volunteers, for 60 minutes at 37°C in 3 separate groups. First with only HgCl2, second with only vitamins (vitamin A and E) and lastly both HgCl2 and vitamins. While MDA levels increased in erythrocytes incubated with HgCl2 alone, SOD, CAT and GPx activities were found to decrease (P < 0.05).
In the literature that we can find, it has been shown that NO and Nitrotyrosine levels increase in almost all of the studies showing the relationship between exposure to mercury and NO, Nitrotyrosine levels. In a study by Kim et al24, they treated rat macrophage cells with mercury, in the presence and absence of lipopolysaccharide, and they found that low-dose mercury reduces lipopolysaccharide-induced NO production in mouse macrophages and may impair immunity by reducing host defense cells. However, in this study by Kim et al., the NO production induced by lipopolysaccharide in macrophages with mercury exposure was examined, the NO levels in the blood is not studied. In our study, the effect of mercury toxicity on NO and Nitrotyrosine, which are blood oxidative stress biomarkers, is investigated in children. In our literature review, we found that the relationship between mercury toxicity and oxidative stress biomarkers was mostly shown in animal studies. Only handfull studies were conducted in humans. We found that NO and Nitrotyrosine levels increased in children diagnosed with mercury intoxication, and we thought that the application of antioxidant therapy to these children in the acute period can reduce oxidative stress.
Our study included 65 patients diagnosed with mercury poisoning as the patient group and 23 outpatients without a history of mercury exposure as the control group. In our study, the effect of mercury toxicity on NO and Nitrotyrosine, which are blood oxidative stress biomarkers, is evaluated in children. In our literature review, we found that the relationship between mercury toxicity and oxidative stress biomarkers has been shown mostly in animal studies, and only a few studies have been conducted in humans. We found that NO and Nitrotyrosine levels increased in children diagnosed with mercury intoxication. Based on our study, we thought that oxidative stress can be reduced by applying antioxidant therapy to these children in the acute period, in addition to chelator therapy in mercury intoxication.
Table 1
Correlations mercury exposure and NO levels
| NO level | Nitrotyrosine level | Mercury level |
Spearman's rho | | NO_level | Correlation Coefficient | 1,000 | ,605** | ,179 |
Sig. (2-tailed) | . | ,000 | ,153 |
N | 88 | 88 | 65 |
| Nitrotyrosine level | Correlation Coefficient | ,605** | 1,000 | ,029 |
Sig. (2-tailed) | ,000 | . | ,819 |
N | 88 | 88 | 65 |
| Mercury level | Correlation Coefficient | ,179 | ,029 | 1,000 |
Sig. (2-tailed) | ,153 | ,819 | . |
N | 65 | 65 | 65 |
**. Correlation is significant at the 0.01 level (2-tailed). |
Table 2
NO levels in the patient and control groups.
| NO (µmol/lt) |
Group | Mean ± sd | min- max | P |
Control group (n = 23) | 5,6452 ± 2,3446 | 1,68 − 10,32 | < 0,001 |
Patient (n = 65) | 12,8420 ± 3,5968 | 7,20–20,40 |
*Statistically significant value: (p < 0.05). sd = standard deviation. |
Table 3
Nitrotyrosine levels in the patient and control groups.
| Nitrotyrosine (nmol/lt) |
Group | Mean ± sd | min- max | p |
Control group (n = 23) | 707,1335 ± 167,2 | 438,90–996,40 | < 0,001 |
Patient (n = 65) | 1004,9655 ± 129,78 | 641,30-1436,30 |
*Statistically significant value: (p < 0.05). sd = standard deviation. |